Recent progress in multidrug delivery to cancer cells by liposomes

Gel-Liposome-Mediated Co-Delivery of Anticancer Membrane-Associated Proteins and Small-Molecule Drugs for Enhanced Therapeutic Efficacy

(2014) Tianyue Jiang et al.   ADVANCED FUNCTIONAL MATERIALS

Enhanced Anticancer Efficacy by ATP-Mediated Liposomal Drug Delivery

(2014) Ran Mo et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Guiding principles in the design of ligand-targeted nanomedicines

(2014) Bingbing Wang et al.   Nanomedicine

Codelivery of VEGF siRNA and Gemcitabine Monophosphate in a Single Nanoparticle Formulation for Effective Treatment of NSCLC

(2013) Yuan Zhang et al.   MOLECULAR THERAPY

Current trends in the use of liposomes for tumor targeting

(2013) Pranali P Deshpande et al.   Nanomedicine

A combination of liposomal sunitinib plus liposomal irinotecan and liposome co-loaded with two drugs enhanced antitumor activity in PC12-bearing mouse

(2012) Yoshie Maitani et al.   JOURNAL OF DRUG TARGETING

Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia

(2012) E.J. Feldman et al.   LEUKEMIA RESEARCH

Two-in-one: combined targeted chemo and gene therapy for tumor suppression and prevention of metastases

(2012) Min Zhang et al.   Nanomedicine

First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

(2011) Eric J. Feldman et al.   JOURNAL OF CLINICAL ONCOLOGY

Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy

(2011) Daniel Zucker et al.   JOURNAL OF CONTROLLED RELEASE

Development of stealth liposome coencapsulating doxorubicin and fluoxetine

(2011) Jasmine Chiat-Ling Ong et al.   JOURNAL OF LIPOSOME RESEARCH

Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model

(2011) Man-Yi Wong et al.   Nanomedicine-Nanotechnology Biology and Medicine

Cationic Liposomal Co-delivery of Small Interfering RNA and a MEK Inhibitor for Enhanced Anticancer Efficacy

(2011) Seung Hee Kang et al.   PHARMACEUTICAL RESEARCH

Experimental Anticancer Therapy with Vascular-disruptive Peptide and Liposome-entrapped Chemotherapeutic Agent

(2010) Aleksander Sochanik et al.   ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS

Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: In vitro and in vivo studies

(2010) Yi-fei Zhang et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Palmitoyl ascorbate-modified liposomes as nanoparticle platform for ascorbate-mediated cytotoxicity and paclitaxel co-delivery

(2010) Rupa R. Sawant et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome

(2010) Wenjing Xiao et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Trilysinoyl oleylamide-based cationic liposomes for systemic co-delivery of siRNA and an anticancer drug

(2010) Gayong Shim et al.   JOURNAL OF CONTROLLED RELEASE

Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy

(2010) Yunching Chen et al.   MOLECULAR THERAPY

Safety, Pharmacokinetics, and Efficacy of CPX-1 Liposome Injection in Patients with Advanced Solid Tumors

(2009) G. Batist et al.   CLINICAL CANCER RESEARCH

Cationic Liposomes Loaded with Proapoptotic Peptided-(KLAKLAK)2and Bcl-2 Antisense Oligodeoxynucleotide G3139 for Enhanced Anticancer Therapy

(2009) Young Tag Ko et al.   MOLECULAR PHARMACEUTICS

Remotely Triggered Liposome Release by Near-Infrared Light Absorption via Hollow Gold Nanoshells

(2008) Guohui Wu et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY